Subsequent 12-month period of time. A combination of chemokine levels may be used to predict flare risk in SLE and to aid in patient management. Competing interests: EBC is entitled to receive royalties under a licensing agreement between LabCorp and the University of Minnesota.CHALLENGES IN CLINICAL LUPUSA11 Major congenital anomalies in children born to women with systemic lupus erythematosus E